Teva Canada Innovation

Teva Canada Innovation is the specialty pharmaceutical division of Teva Canada, a subsidiary of Teva Pharmaceutical Industries Ltd. The company focuses on delivering innovative treatments in core therapeutic areas including central nervous system (CNS) disorders, respiratory diseases, and oncology. Its portfolio features prominent brands such as Copaxone for multiple sclerosis and Ajovy for migraine prevention. Teva Canada Innovation operates as a distinct entity from the company's generic division, emphasizing research-driven solutions and patient support programs. The organization plays a critical role in bringing Teva's global pipeline of specialty medicines to the Canadian market.